Becker's Healthcare November 18, 2024
Jakob Emerson

Blue Cross and Blue Shield of Massachusetts reported a $114 million operating loss in the first nine months of the year, partly due to skyrocketing claims for GLP-1 medications.

Five notes:

1. BCBSMA reported an after-tax third quarter net income of $29.2 million on revenue of $2.4 billion (1.21% net margin).

2. Year-to-date, BCBSMA reported an after-tax net income of $27.1 million on revenue of $7.2 billion (0.38% net margin).

3. The company’s operating loss in the third quarter was $19.8 million. Compared to a year ago, Q3 operating income is down $145 million and net income...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Payer, Pharma / Biotech
Offering health insurance is becoming less lucrative
Inside the Justice Department’s Amedisys-Optum Lawsuit
Payer executives expect limited change in ACA subsidies
5 payer updates shaking up the ASC industry
Commercial, individual markets growing increasingly concentrated: 7 numbers to know

Share This Article